English

English
Castellano
Català

Arabic

Institute
Research
Core facilities
Innovation
News
Events
Outreach
Management
Directory
Careers

Publications

Home Publications Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma

Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma

Twitter
Facebook
Linkedin
Whatsapp
Telegram

Contact us

Social media

We are

Recognised by

2025 © Josep Carreras Leukaemia Research Institute

Legal disclaimer
Cookies policy
Whistleblowing Channel